GERM
Amplify Treatments, Testing and Advancements ETF
GERM
GERM
Delisted
GERM was delisted on the 5th of September, 2024.
20 hedge funds and large institutions have $4.24M invested in Amplify Treatments, Testing and Advancements ETF in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.31M | |
| 2 | +$809K | |
| 3 | +$742K | |
| 4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$432K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$213K |
Top Sellers
| 1 | -$143K | |
| 2 | -$11K | |
| 3 | -$5.71K | |
| 4 |
TWA
TCI Wealth Advisors
Tucson,
Arizona
|
-$1.8K |